CXCR2 inhibition in pancreatic cancer: opportunities for immunotherapy?

Morton, J. P. and Sansom, O. J. (2017) CXCR2 inhibition in pancreatic cancer: opportunities for immunotherapy? Immunotherapy, 9(1), pp. 9-12. (doi:10.2217/imt-2016-0115) (PMID:28000523)

Full text not currently available from Enlighten.

Abstract

No abstract available.

Item Type:Articles (Editorial)
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Morton, Dr Jennifer and Sansom, Professor Owen
Authors: Morton, J. P., and Sansom, O. J.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
Journal Name:Immunotherapy
Publisher:Future Medicine
ISSN:1750-743X
ISSN (Online):1750-7448
Published Online:21 December 2016

University Staff: Request a correction | Enlighten Editors: Update this record